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Summary
Background. Cervical spinal cord stimulation (SCS) has been shown
to augment cerebral blood flow (CBF) and protect the brain from focal
ischemia. However, the application of SCS in the treatment of cerebral
ischemia requires a better understanding of the limits of the cerebrovas-
cular effect and the optimal stimulation parameters. In the present study,
we investigated the effects of various stimulation parameters on CBF
augmentation, as well as the issue of tachyphylaxis of the CBF response.
Methods. SCS was performed in adult Sprague Dawley rats, and CBF
was assessed using cortical laser Doppler flowmetry (LDF). In separate
experimental series, stimulation amplitude, frequency, and pulse width
were varied, and the effect on the LDF response was recorded. Finally,
using the stimulation parameters found to elicit the strongest LDF
response, we examined the effect of lengthening the period of SCS.
Findings. SCS elicited a robust increase in cortical LDF values as
previously demonstrated. The magnitude of the response varied in a
dose-dependent fashion with the stimulation amplitude. LDF values
increased by more than 80% over baseline with an amplitude of
1.5 mA. The optimal pulse width and frequency of the stimulation were
0.25 ms and 50 Hz, respectively. Lengthening the stimulation period up
to 20 minutes resulted in a persistent increase in cerebral LDF values
during the entire stimulation period, although the magnitude of this effect
diminished to approximately 50% over the baseline after 10 minutes.
Conclusions. SCS elicits a robust augmentation in CBF, which lasts
the entire stimulation duration. Stimulation parameters required for
optimal cerebrovascular response are within normally used therapeu-
tic ranges in the clinical settings. These results provide further evidence
that SCS may provide a novel therapeutic strategy for the treatment of
cerebral ischemia.
Keywords: Spinal cord stimulation; cerebral blood flow; parameter;
tachyphylaxis; rat.
Introduction
Electrical stimulation of the spinal cord is an effec-
tive therapeutic modality for the treatment of various
pain syndromes [5, 17, 24]. The effect of spinal cord
stimulation (SCS) on peripheral blood flow has been
well-described in experimental studies [19, 20] and
clinical reports [7, 11, 18], leading to the use of SCS in
the treatment of painful peripheral ischemia [14, 32, 34].
The effect of SCS on peripheral vascular tone has
prompted clinicians and investigators to examine the
effects of stimulation on myocardial blood flow
[1, 12] and cerebral blood flow (CBF) [6, 10, 15]. In
both cases, there is mounting evidence that SCS may
meaningfully increase tissue perfusion. The treatment
of angina with SCS, for example, has been studied in a
large clinical trial which has demonstrated significant
symptomatic relief and protection from fatal myocar-
dial events comparable to direct coronary revasculariza-
tion [2, 8, 13]. Clinical experience in the use of SCS in
peripheral vascular disease and angina has resulted in
the widespread use of this modality for the treatment
of ischemia.
The possibility that SCS may be used to augment CBF
stems from the observation of Hosobuchi et al. [15],
who noted that global CBF increased in a small cohort
of patients treated with SCS for chronic pain. Subse-
quently, several investigators have demonstrated CBF
changes in response to SCS in animal models. Garcia
et al. [10] observed that SCS increased hemispheric
blood flow with a mean of 55% in goats and dogs as
measured by laser Doppler flowmetry. Quantitative mea-
surements with iodoantipyrine also demonstrated a
significant increase in CBF. Experimentally induced
cerebral ischemia has also found to be ameliorated by
SCS in cats [21], rabbits [39] and rats [27, 30, 31].
Finally, anecdotal clinical reports of SCS have corrobo-
rated these experimental findings [22, 23].
The promise of SCS-induced CBF augmentation has
led some clinicians to use this procedure in the treatment
of cerebral ischemia [4]. However, the parameters used
in SCS to augment CBF have been arbitrarily deter-
mined, and it is unknown whether a dose-dependent
effect exists in this phenomenon. In the present study,
we investigated the effects of modulating stimulation
parameters on the cerebrovascular response. In addition,
we examined the effects of prolonged stimulation on
CBF. Such basic study is crucial and will allow more
effective clinical utilization of this technique in the treat-
ment of cerebral ischemia.
Methods and materials
Animal preparation
All experimental protocols were approved by the University of
Michigan Committee on the Use and Care of Animals. Adult male
Sprague-Dawley rats, each weighing between 250 and 350 grams, were
selected for the experimental series. The animals were housed in standard
conditions in a laboratory environment with free access to food and
water. Care was taken to minimize stress and nociceptive input to the
animals before and during surgery. General anesthesia was induced with
5% isoflurane (Aerrane). After intubation and initiation of mechanical
ventilation with a rodent ventilator (model 683; Harvard Apparatus, Inc.,
S. Natick, MA), isoflurane was titrated between 1.5–2.25% to maintain a
mean arterial pressure between 80 and 120 mmHg and a normal PaCO2
level between 35–45 mmHg. The concentration of isoflurane was held
constant during the experiment. The rats were paralyzed with gallamine
(Sigma Chemical Co., St. Louis, MO) 10 mg=kg i.v. as a muscle relaxant.
The animal’s body temperature was maintained at 37  0.5 C with an
automatic heating device (model 73A-YSI; Yellow Springs Instruments,
Yellow Springs, OH). The femoral artery was cannulated for continuous
monitoring of arterial blood pressure and arterial blood gas levels.
Cerebral blood flow measurement
A midline incision was made to expose the skull and cervical spine. A
microsurgical drill was then used to create a 2.5-mm-diameter burr hole
6 mm lateral and 1 mm posterior to the bregma, as previously described
[27]. To ensure reproducibility of recording, this location was held
constant. Great care was taken to maintain dural integrity. Real-time
cortical blood flow was then recorded continuously by using a laser
Doppler flowmeter (LDF) (Laserflow BMP2; Vasamedics, Inc., Little
Canada, MN). Using the stereotactic apparatus, a 2-mm-diameter probe
was introduced into the burr hole. Great care was taken to maintain pial
membrane integrity. The probe was not cemented into place, as there
was no significant movement in this preparation. All data were collected
and recorded on a Macintosh computer using standard charting software
(Chart V4.1.1; ADInstruments; Mountain View, CA).
Spinal cord stimulation
The animal was placed in a stereotactic frame (model 900; Kopf
Instruments, Tujunga, CA). A midline incision was made from the occiput
to the cervical spine. The first and second lamina were identified and
cleared of paraspinous muscles. A laminectomy between C1 and C2 was
performed, sparing the dura. Meticulous hemostasis was maintained to
keep the dorsal surface of spinal dura dry for the duration of the experi-
ment. A standard stimulation setup was used, which consisted of a stim-
ulator (model S48; Grass Instruments, Quincy, MA), a constant-current
unit (model CCU1-A; Grass Instruments) and an oscilloscope (model
5111-A; Tektronix, Gaithersburg, MD). A ground electrode was placed
in the left proximal hindquarters of the rat. A 1-mm platinum-ball elec-
trode mounted on a stereotactic electrode holder was then lowered onto
the exposed dorsal dural surface in the midline. After a stable LDF value
baseline was established, monopolar electrical simulation was performed.
SCS parameter testing protocol
Amplitude
In the first series of experiments, we examined the effect of SCS
amplitude on CBF response. Prior experiments have determined that
the motor threshold in the rat is approximately 1.8 mA (unpublished
data). Since it is unlikely that stimulation amplitudes exceeding motor
threshold would be therapeutically meaningful, we selected 1.8 mA as
the maximum amplitude tested. Setting the pulse width and frequency at
the previously described settings of 0.1 ms and 50 Hz [30], we varied the
stimulation amplitude. Each animal underwent three 2-minute stimula-
tion periods, each followed by a rest period of 8–12 minutes. Stimula-
tion amplitudes were chose randomly amongst 0.1, 0.4, 0.8, 1.2, 1.5 and
1.8 mA. LDF was measured continuously, and recorded for the entire
duration of each experiment.
Pulse width
Utilizing the stimulation amplitude found to elicit the most robust
increase in LDF values, we tested the effect of various stimulation pulse
width values between 0.1 to 0.5 ms, while fixing the frequency at 50 Hz.
The range of tested pulse widths is well-within clinically utilized param-
eters in SCS. Once again, the stimulation period was 2 minutes and the
rest interval between each of the three stimulation periods was 8–12
minutes. CBF was measured continuously in a fashion similar to that
used in the first experimental series.
Frequency
The third series of experiments examined the effect of stimulation
frequency on the CBF response. Utilizing the pulse width and amplitude
found to elicit the most robust increase in LDF values, we tested the
effect of various stimulation frequencies between 25 and 100 Hz. As
above, the stimulation duration was 2 minutes with an interval of 8–12
minutes between each of the three stimulation periods. LDF values were
recorded for the entire duration of the experiment.
Duration
The issue of tachyphylaxis is a crucial one in determining the clinical
utility of SCS in cerebral ischemia. Within the framework of this experi-
mental stimulation model, it is not possible to test the effect of prolonged
stimulation (e.g., hours, days). Therefore, we investigated the durability
of the SCS response up to a maximal duration of 20 minutes. With those
basic SCS parameters (pulse width, amplitude and frequency) obtained
to elicit the most robust increase in LDF values, we extended the
stimulation duration from 2 minutes to 5, 10 or 20 minutes. LDF values
were recorded for the entire duration of each experiment.
Statistical analysis
Changes in LDF measurements were expressed as percentages of
baseline values (% LDF) and presented as mean  standard error of
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the mean. % LDFs in both of the stimulation and rest periods were
averaged. Mean % LDFs in different groups were compared. Compar-
isons of values were made by using the two-tailed unpaired Student t-test
and single factor ANOVA with post-hoc analysis using Bonferroni=Dunn
test. Statistical significance was accepted at P<0.05.
Results
Effect of SCS amplitude
SCS induced a robust increase in cerebral LDF values,
consistent with previous findings. The degree of LDF
Table 1. Mean D% LDFs in response to stimulation amplitudes
Amplitude 0.1 mA 0.4 mA 0.8 mA 1.2 mA 1.5 mA 1.8 mA
n 8 7 6 10 6 7
SCS 0.3  0.4% 2.6  0.7% 11.8  1.3% 37.3  2.5% 49.0  2.5%;# 45.2  3.7%
Post-SCS 0.4  0.5% 3.2  1.0% 1.3  1.4% 9.8  1.6% 7.8  3.0% 12.0  2.6%
 P<0.01 vs. baseline; # P<0.001 vs. 0.1, 0.4, 0.8 and 1.2 mA groups.
% LDF: Cerebral blood flow changes compared to the baseline measured by the laser Doppler flowmetry; SCS: during the 2-minute stimulation
period; Post-SCS: in 8 minutes after the stimulation. The stimulation frequency and pulse width are set at 50 Hz and 0.1 ms, respectively. Values are
expressed as mean  SE.
Fig. 1. Graph showing the effect of stimulation amplitude on LDF changes. The stimulation frequency and pulse width are set at 50 Hz
and 0.1 ms, respectively. % LDF: the percentage CBF change compared to the baseline measured by LDF. Values are expressed as
meanSE
Table 2. Mean D% LDFs in response to stimulation pulse widths
Pulse width 0.1 ms 0.25 ms 0.5 ms
n 6 14 6
SCS 49.0  2.5% 67.6  2.7%;# 22.0  2.5%
Post-SCS 7.8  3.0% 5.9  1.9% 9.5  2.6%
 P<0.001 vs. baseline; # P<0.001 vs. other pulse width groups.
% LDF: Cerebral blood flow changes compared to the baseline
measured by the laser Doppler flowmetry; SCS: during the 2-minute
stimulation period; Post-SCS: in 8 minutes after the stimulation. The
frequency and amplitude are set at 50 Hz and 1.5 mA, respectively.
Values are expressed as mean  SE.
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augmentation varied in a dose-dependent fashion with
stimulation amplitude. At the lowest SCS amplitude
tested (0.1 mA), there was no significant increase in
LDF values. In animals undergoing stimulation at the
current amplitude of 1.5 mA, the average increase in
LDF value was approximately 50% over baseline
(P<0.001). This stimulation amplitude induced the
largest increase in LDF value in the range of amplitudes
tested (Table 1 and Fig. 1).
Effect of SCS pulse width
In this series of experiments, we held stimulation
amplitude and frequency constant at 1.5 mA and 50 Hz,
respectively. When varying the pulse width between
0.1 and 0.5 ms, we noted that the maximal increase in
LDF values occurred in the 0.25-ms group. In those ani-
mals undergoing SCS with a 0.25-ms pulse width, the
average increase in LDF was 67.6  3.3% (P<0.001
vs. other groups) over the 2-minute stimulation period,
with a mean peak value of greater than 80%. Increasing
pulse width to 0.5 ms did not improve the CBF response
(Table 2 and Fig. 2).
Effect of SCS frequency
We examined the frequency modulation SCS effect on
the cerebrovascular response by holding the stimulation
amplitude and pulse width constant at 1.5 mA and
0.25 ms, respectively. When the stimulation frequency
varied from 25 to 100 Hz, the maximal increase in
LDF value still occurred in the 50-Hz group (P<0.001
vs. other groups). Mean % LDFs in the 2-minute SCS
and following 8-minute rest period are shown in Table 3.
The time course of mean % LDF using different
Fig. 2. Graph illustrating the effect of stimulation pulse width on LDF changes. The stimulation frequency and amplitude are set at 50 Hz
and 1.5 mA, respectively. % LDF: the percentage CBF change compared to the baseline measured by LDF. Values are expressed as
meanSE
Table 3. Mean D% LDFs in response to stimulation frequencies
Frequency 25 Hz 50 Hz 100 Hz
n 6 14 8
SCS 21.2  2.0% 67.6  2.7%;# 26.6  1.7%
Post-SCS 2.3  5.9% 5.9  1.9% 0.5  1.8%
 P<0.001 vs. baseline; # P<0.001 vs. other frequency groups.
% LDF: Cerebral blood flow changes compared to the baseline
measured by the laser Doppler flowmetry; SCS: during the 2-min
stimulation period; Post-SCS: in 8 min after the stimulation. The
stimulation amplitude and pulse width are set at 1.5 mA and 0.25 ms,
respectively. Values are expressed as mean  SE.
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stimulation frequency during the entire experimental
period is illustrated in Fig. 3.
Effect of SCS duration
Using stimulation parameters of 0.25-ms pulse width,
1.5-mA amplitude and 50-Hz frequency and extending
the SCS period up to 20 minutes, we observed a per-
sistent and robust increase in cerebral LDF values
during the entire stimulation period. The average
value of % LDF in consecutive 5-minute epochs
was 60.0  1.6%, 61.1  2.3%, 53.2  5.2% and
46.3  5.8%, respectively. There was no statistically
difference among the first three 5-minute epochs, but
the response appeared to diminish somewhat in the
last 5-minute epochs (P<0.001 vs. 1st and 2nd epoch).
Mean % LDF values during and after the stimulation
periods in various SCS-length groups are listed in
Table 4. After stimulation, LDF values gradually re-
turned toward baseline values, reaching a level within
10% of the original baseline by 8 minutes following the
cessation of stimulation. Figure 4 delineates the time
course of mean % LDFs in various SCS-length
groups.
Fig. 3. The effect of stimulation frequency on LDF changes. The stimulation pulse width and amplitude are set at 0.25 ms and 1.5 mA, respectively.
% LDF: the percentage CBF change compared to the baseline measured by LDF. Values are expressed as mean SE
Table 4. Mean D% LDFs in response to stimulation durations
SCS-Duration 2 minutes 5 minutes 10 minutes 20 minutes
n 14 6 14 6
SCS 67.6  2.7% 66.2  3.4% 61.7  2.4% 52.4  2.3%;#
Post-SCS 5.9  1.9%x 9.7  3.1%x 9.1  1.6%x 2.7  1.6%
 P<0.001 vs. baseline; x P<0.001 vs. baseline; # P<0.001 vs. other duration groups.
% LDF: Cerebral blood flow changes compared to the baseline measured by the laser Doppler flowmetry; SCS: during the stimulation period; Post-
SCS: in 8 minutes after the stimulation. The stimulation amplitude, frequency and pulse width are set at 1.5 mA, 50 Hz and 0.25 ms, respectively.
Values are expressed as mean  SE.
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Discussion
Spinal cord stimulation has been used for the treat-
ment of chronic pain over the last three decades. Clinical
observations and recent experimental studies have sug-
gested clinical utility of this modality in the treatment of
ischemia as well as other conditions, such as early cere-
bral vasospasm [35], stroke [38], postapoplectic spastic
hemiplegia [26] and prolonged coma [9]. The successful
use of SCS in the treatment or prevention of ischemia
hinges on an understanding of the underlying mecha-
nisms, clinically relevant parameters and limitations of
this technique.
The augmentative effect of SCS on CBF has been
demonstrated in a number of animal models and early
clinical studies. Previous studies have indicated that
spinal cord stimulation results in an increase in cerebral
blood flow in a number of animal models, and that this
increase is dependent on the spinal level of stimulation.
Previous studies in our laboratory have indicated that the
SCS effect on CBF may involve indirect effects on cen-
ters in the brainstem as well as an alteration in sympa-
thetic tone [28, 30]. Sympathetic tone appears to play a
major role in SCS-induced CBF augmentation [37], and
this sympathetic response is mediated primarily by
1-adrenergic receptors [27]. These lines of evidence
suggest that cervical SCS modulates activity within
autonomic vasomotor nuclei in the brainstem, thereby
increasing CBF [29].
As the use of SCS to increase blood flow becomes more
widespread, it is necessary to delineate the effects of var-
ious stimulation parameters on this response and examine
its durability. Up until now, few studies have examined
the effects of altering stimulation parameters in the clinical
setting [3]. Tulgar et al. [33] investigated 1,100 electrode
combinations at various spinal levels. When utilizing
210ms long rectangular monophasic pulses delivered at
a constant frequency of 50 Hz, the authors found that at
the level of C2–C3, the perception and tolerance thresh-
old were 1.23 0.09 and 1.68 0.11 mA, respectively.
Miles [25] recommended keeping the treatment level half
way between the perception threshold and the tolerance
threshold. While no clinical study has examined SCS
parameters in the CBF response, a limited experimental
study has suggested that lower stimulation frequencies
(<200 Hz) are associated with augmentation of CBF. In
this study, Isono et al. [16] found that the stimulation
frequencies of 200 and 2,000 Hz did not result in a CBF
increase, whereas a moderately low frequency (20 Hz)
increased CBF significantly.
Fig. 4. The effect of stimulation duration on LDF changes. The stimulation pulse width, frequency and amplitude are set at 0.25 ms, 50 Hz and
1.5 mA, respectively. % LDF: the percentage CBF change compared to the baseline measured by LDF. Values are expressed as mean SE
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The present study extends and further defines the
parameters of stimulation necessary to elicit a significant
cerebrovascular response. The stimulation amplitude,
pulse width and rate found to be associated with a max-
imal rise in cerebral LDF values are all well-within
commonly utilized parameter ranges [36]. This study
therefore supports the clinical utility of SCS in the aug-
mentation of cerebral blood flow. Moreover, this study
suggests that tachyphylaxis to the effect of SCS on CBF
does not seem to limit its effectiveness in the experi-
mental model. This finding is corroborated by previously
described neuroprotection in a focal cerebral ischemia
model [31].
In the present study, we employed LDF as a measure-
ment to achieve a real time CBF recording. Although the
use of LDF does not allow one to examine the spatial
characteristics or absolute magnitude of the observed
blood flow changes, this technique provides a continuous
record of CBF changes during the SCS period as well as
the pre- and post-SCS period. LDF has previously been
validated against quantitative CBF measures in this
model [31]. Investigation of the long-term effects of
SCS on CBF requires its study in awake animals.
SCS provides an encouraging therapeutic option for
the treatment and prevention of cerebral ischemia. The
study of SCS in an experimental setting has allowed
delineation of the likely underlying mechanism(s) and
now provides some initial guideline in its clinical imple-
mentation. Further study of tachyphylaxis of the effect
in awake animals will be required in order to fully real-
ize the potential of this therapy before clinical studies
can be pursued.
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Comments
This is an experimental study on the effect of cervical spinal cord
stimulation (SCS) on cerebral blood flow augmentation. The authors
have investigated various stimulation parameters (amplitude, pulse width
and frequency) to find out the optimal setting for the most pronounced
effect on CBF.
In addition, at least in this animal model, an increase in CBF was
noted as long as the stimulation was continued with no signs of tachy-
phylaxis.
This is a well designed and carefully conducted study providing some
useful information on the increase of CBF elicited by SCS.
The observation that SCS results in increased peripheral and central
blood flow has been around for some time. In fact, it has been used
clinically for the treatment of angina pectoris and peripheral ischaemic
disease. So far, it has not been used on a large scale for cerebral
ischaemic conditions. The reason for this may be that we still do not
know the mechanism of action how SCS leads to an increase of CBF.
In addition, it is a rather invasive method thereby preventing it’s
widespread clinical application. However, one could imagine that the




Spinal cord stimulation (SCS) affects peripheral, coronaric and cere-
bral blood flow (CBF) in humans. Functional reversible sympathectomy
may be one of the mechanisms put in play by SCS to produce such
effects. One of the most fascinating effects of SCS is the possibility to
interfere with the mechanisms of regulation of the cardiovascular system.
In this paper the Authors investigate on the parameters influencing
augmentation of CBF by SCS. The aim is to increase the interest in SCS
as possible therapy (treatment and prevention) of cerebral ischaemia in
humans. The paper has some limits related to the choice of an animal
(rat) target rather than the human’, the type of CBF assessment (not
global but unilateral CBF investigation) but deserves consideration
because confirm the interest on neurosurgeons on this topic.
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